Having earlier this year outlined plans for international expansion, liquids specialist Rosemont has made its first venture outside the UK by acquiring Greek R&D organization Pharma-Data.
UK liquids specialist Rosemont Pharmaceuticals has delivered on promises to expand outside of its domestic market by striking a deal to acquire privately-owned Greek R&D organization Pharma-Data.
Indicating that the acquisition “enhances [our] ability to develop products for the global market,” Rosemont noted that Pharma-Data specializes in...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
